YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Lyrica


AddThis Social Bookmark Button

Lyrica May Be Linked to Suicide


Keywords: Lyrica Suicide Side Effects Lawyer Lawsuit Neurontin

Lyrica & Neurontin Association
Lyrica (Generic: Pregabalin) is prescribed to patients for the management of neuropathic pain associated with diabetic peripheral neuropathy. Lyrica, manufactured by Pfizer, received FDA approval on December 30, 2004. Seizure patients also use Lyrica. Lyrica was manufactured as a substitute medication for Neurontin. Lyrica has only been tested and prescribed to adults 18 or older. Lyrica has not been studied in children under the age of 18. Lyrica, just like Neurontin, may cause increased risk of suicide and suicidal behavior.

Other Lyrica Side Effects
General side effects associated with Lyrica can include: dizziness, blurred vision, sleepiness, weight gain, swelling (edema), muscle problems, and altered perception. Weight gain is of particular concern to those with diabetes, as this can worsen their condition. Additional animal studies also found Lyrica to cause side effects in males. Lyrica lowered the fertility of some male animal subjects throughout testing. Males who received Lyrica who did reproduce had an increased risk of birth defects in their offspring.

Free Lawsuit Case Evaluation
If you or a loved one took Lyrica and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.

LyricaRSS Feed

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and behavior. The Food & Drug Administration (FDA) is set to ask an outside advisory panel for its recommendations on the proposed black box at a meeting this Thursday.   In total, 11 epilepsy drugs could get the new black box warning - the FDA's strongest safety notice. They include:Carbamazepine (marketed as Carbatrol, Equetro, Tegretol,...

New Suicide Warning for Epilepsy Drugs

Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior.  The analysis was released this week and confirmed earlier findings.  "The effect appears consistent among the group of 11 drugs" that were reviewed, according to a summary from statistical reviewers at the Food and Drug Administration (FDA).  In the review dated May 23, the FDA staff said that there were about two more cases of suicidal...

Epilepsy Drugs to Get Suicide Warnings, FDA Confirms

Jun 6, 2008 | Parker Waichman Alonso LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today.  This past January, the Food & Drug Administration (FDA) issued an Early Communication announcing a safety review of the epilepsy drugs after a study showed they increased patients' risk of suicidal thoughts and behavior. The 11 epilepsy drugs slated for a new suicide warning are: Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR)...

Epilepsy Drugs Double Suicide Risks, FDA Warns

Feb 2, 2008 | Parker Waichman Alonso LLP
Epilepsy drugs have been linked to a increased risk of suicidal thoughts and behavior, the Food & Drug Administration (FDA) warned this week.  According  to an FDA analysis, people taking antiepileptic drugs are twice as likely to experience suicidal thoughts or behavior than those taking placebo.The FDA began investigating if epilepsy drugs pose any suicide risk in 2005.  In doing so, the FDA analyzed almost 200 studies of 11 anti-seizure drugs, some that have been on the...

More Lyrica News

Lyrica
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Was suicide attempted?


Did loved one commit suicide?


What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

If patient did commit suicide, what was the method of suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?


Please describe any psychiatric conditions diagnosed before starting Lyrica:

Did Lyrica help the condition that it was prescribed for?

Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News